Evidence map›Paper›PMID 41681913›Full record

ArticleCancers2026

Lentiviral Dendritic Cell Vaccine Targeting Claudin-18.2 Elicits Potent Antitumor Immunity Against Gastric Cancer.

Bowen Zheng, Wenqing Zhang, Dan Zhou, Miao Fu, Fanzhuoran Lou, Xintian Huang, Xiaowen Xie, Yunli Gong, Kaiyi Rong, Yongxiang Hong and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bowen ZhengXiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen 361102, China.ORCID 0009-0001-5773-0851
Wenqing ZhangXiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen 361102, China.
Dan ZhouFujian-Taiwan Smart Health and Elderly Care Research Center, Xiamen City University, Xiamen 361008, China.
Miao FuXiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen 361102, China.
Fanzhuoran LouDepartment of Oncology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China.
Xintian HuangDepartment of Oncology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China.
Xiaowen XieXiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen 361102, China.
Yunli GongXiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen 361102, China.
Kaiyi RongDepartment of Oncology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China.
Yongxiang HongDepartment of Oncology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China.
Yanyan ZhanXiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen 361102, China.
Li XiaoDepartment of Oncology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China.ORCID 0000-0002-8889-9609
Tianhui HuXiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen 361102, China.ORCID 0000-0003-3998-5145

Funding

Natural Science Foundation of Fujian Province 20247011335the Open Research Project of the Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (Ministry of Education), Gannan Medical University XN202005the Scientific Research Foundation of State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory 2023XAKJ0101005the Shenzhen Science and Technology Program JCYJ20210324121802008, JCY20220530143406015the Start-up Fund for University-level Academic Leaders at Xiamen City University 20104028the Xiamen Natural Science Foundation Project 3502Z20227266, 3502Z202573104
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Claudin-18.2 (CLDN18.2)cytotoxic T lymphocytesdendritic cell vaccinegastric cancerimmunotherapy

Identifiers

PMID41681913
PMCPMC12897038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.